Cargando…
Novel coronavirus disease in patients with end‐stage kidney disease
The novel coronavirus disease outbreak started in Wuhan, China, in December 2019 and has since spread rapidly worldwide. As almost all patients with end‐stage kidney disease have been treated with HD in Japan, they have a higher risk of infection than the healthy population. Moreover, the complicati...
Autores principales: | Shimada, Noriaki, Shimada, Hiroaki, Itaya, Yoshiaki, Tomino, Yasuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675310/ https://www.ncbi.nlm.nih.gov/pubmed/33040443 http://dx.doi.org/10.1111/1744-9987.13599 |
Ejemplares similares
-
Ankle‐brachial index, arterial stiffness, and biomarkers in the prediction of mortality and outcomes in patients with end‐stage kidney disease
por: Otsuka, Kenichiro, et al.
Publicado: (2019) -
Coronavirus Disease 2019 in Patients With End-Stage Kidney Disease on Hemodialysis in Guatemala
por: Sosa, Regina, et al.
Publicado: (2021) -
End of Life Care in End-Stage Kidney Disease
por: Prabhu, Ravindra Attur, et al.
Publicado: (2021) -
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
por: Liu, Wen-Chih, et al.
Publicado: (2018) -
Preoperative Evaluation in Patients With End-Stage Renal Disease and Chronic Kidney Disease
por: Nasr, Rabih, et al.
Publicado: (2017)